The Food and Drug Administration (FDA) has certified a new Covid-19 antibody drug for people with high-risk health problems or allergies who can’t get protection from vaccination. The antibody-drug is authorised for long-term protection against the Covid-19 virus rather than short-term treatment.
People who can benefit from the antibody drug are cancer patients, organ transplant recipients and patients taking immune-suppressing drugs for diseases like rheumatoid arthritis. Health experts say that approximately 2 to 3 per cent of the population of the US is into that group.
- Anthropic IPO at $1.5 Trillion: What It Means for Indian Stock Markets and AI Investors
- Ashoka Buildcon Loses Rs 846 Crore Saudi Arabia Contract
- South Korea Becomes Fourth Country to Cross $1 Trillion in Exports
- Humyn Labs Raises $47 Million in Series A Funding
- ArMee Infotech Signs Rs 1,629 Cr Solar MoU With MSEDCL
The FDA and other health officials have highlighted that antibody drugs are not a replacement for vaccines, the most effective, long-lasting and protection again coronavirus. Antibody drugs are hard to manufacture and cost over $1,000 per dose compared with regular vaccines, usually under $30 per dose.
Live
